PT3679025T - Imidazoquinolinas substituídas como agonistas de tlr7 - Google Patents

Imidazoquinolinas substituídas como agonistas de tlr7

Info

Publication number
PT3679025T
PT3679025T PT187696034T PT18769603T PT3679025T PT 3679025 T PT3679025 T PT 3679025T PT 187696034 T PT187696034 T PT 187696034T PT 18769603 T PT18769603 T PT 18769603T PT 3679025 T PT3679025 T PT 3679025T
Authority
PT
Portugal
Prior art keywords
tlr7
agonists
substituted imidazoquinolines
imidazoquinolines
substituted
Prior art date
Application number
PT187696034T
Other languages
English (en)
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of PT3679025T publication Critical patent/PT3679025T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT187696034T 2017-09-06 2018-08-31 Imidazoquinolinas substituídas como agonistas de tlr7 PT3679025T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2017072353 2017-09-06

Publications (1)

Publication Number Publication Date
PT3679025T true PT3679025T (pt) 2022-06-01

Family

ID=63586658

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187696034T PT3679025T (pt) 2017-09-06 2018-08-31 Imidazoquinolinas substituídas como agonistas de tlr7

Country Status (22)

Country Link
US (2) US11279684B2 (pt)
EP (2) EP4098652A1 (pt)
JP (1) JP7304848B2 (pt)
KR (1) KR20200050964A (pt)
CN (1) CN111132969B (pt)
AU (1) AU2018329152B2 (pt)
BR (1) BR112020004505A2 (pt)
CA (1) CA3074611A1 (pt)
DK (1) DK3679025T3 (pt)
ES (1) ES2914800T3 (pt)
HR (1) HRP20220669T1 (pt)
HU (1) HUE058995T2 (pt)
IL (1) IL273039B2 (pt)
LT (1) LT3679025T (pt)
MX (1) MX2020002366A (pt)
PL (1) PL3679025T3 (pt)
PT (1) PT3679025T (pt)
RS (1) RS63265B1 (pt)
SG (1) SG11202001926QA (pt)
SI (1) SI3679025T1 (pt)
WO (1) WO2019048353A1 (pt)
ZA (2) ZA202001267B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7386536B2 (ja) 2017-08-22 2023-11-27 ダイナヴァックス テクノロジーズ コーポレイション アルキル鎖修飾イミダゾキノリンtlr7/8アゴニスト化合物およびその使用
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES
SG11202108752YA (en) * 2019-03-07 2021-09-29 BioNTech SE Process for the preparation of a substituted imidazoquinoline
US20230248835A1 (en) * 2020-07-08 2023-08-10 Purdue Research Foundation Compounds, compositions, and methods for the treatment of fibrotic diseases and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
MY157827A (en) 2003-06-27 2016-07-29 3M Innovative Properties Co Sulfonamide substituted imidazoquinolines
CA2547085A1 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
NZ588183A (en) 2008-03-24 2012-05-25 4Sc Discovery Gmbh Novel substituted imidazoquinolines
US10150768B2 (en) 2015-08-31 2018-12-11 3M Innovative Properties Company Guanidine substituted imidazo[4,5-c] ring compounds
WO2019048036A1 (en) 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES

Also Published As

Publication number Publication date
DK3679025T3 (da) 2022-06-07
HRP20220669T1 (hr) 2022-08-19
IL273039B1 (en) 2023-06-01
KR20200050964A (ko) 2020-05-12
CA3074611A1 (en) 2019-03-14
ZA202101323B (en) 2022-09-28
EP3679025A1 (en) 2020-07-15
BR112020004505A2 (pt) 2020-09-15
AU2018329152B2 (en) 2024-02-15
US20210002249A1 (en) 2021-01-07
EP3679025B8 (en) 2022-06-15
EP3679025B1 (en) 2022-05-04
ZA202001267B (en) 2021-07-28
SG11202001926QA (en) 2020-04-29
IL273039A (en) 2020-04-30
RU2020112231A3 (pt) 2021-10-06
IL273039B2 (en) 2023-10-01
EP4098652A1 (en) 2022-12-07
RU2020112231A (ru) 2021-10-06
SI3679025T1 (sl) 2022-07-29
RS63265B1 (sr) 2022-06-30
US11279684B2 (en) 2022-03-22
US20220242845A1 (en) 2022-08-04
AU2018329152A1 (en) 2020-03-19
CN111132969B (zh) 2024-01-30
ES2914800T3 (es) 2022-06-16
JP2020532571A (ja) 2020-11-12
HUE058995T2 (hu) 2022-10-28
PL3679025T3 (pl) 2022-07-11
JP7304848B2 (ja) 2023-07-07
US11987569B2 (en) 2024-05-21
WO2019048353A1 (en) 2019-03-14
MX2020002366A (es) 2020-07-20
LT3679025T (lt) 2022-06-27
CN111132969A (zh) 2020-05-08

Similar Documents

Publication Publication Date Title
IL272888A (en) Uses of piperidinyl-indole derivatives
SG11201706729SA (en) Derivatives of sobetirome
IL263050B (en) History of Subtirum
ZA202101323B (en) Substituted imidazoquinolines as agonists of tlr7
EP3386935A4 (en) PREPARATION OF XYLENE DERIVATIVES
FI3943070T3 (fi) Pitkävaikutteisia bedakiliiniformulaatioita
ZA202101322B (en) Substituted imidazoquinolines
GB201511156D0 (en) Production of alkaloids
IL278933A (en) TLR7 agonists
IL293192A (en) Methods for the preparation of indolinobenzodiazepine derivatives
IL270703A (en) History of Reziquimod
IL255182A0 (en) History of korormicim with antibiotic use
IL266121A (en) A history of metamorphosed quinoxaline as an inhibitor of pfkfb
GB201520346D0 (en) Stable amorphous form of daclatasvir
HK1247826A1 (zh) 吡咯甲酰胺的固體組合物
GB201502834D0 (en) Composition of objects
HUP1400294A2 (hu) Clopidogrel új alkalmazása
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects